# ECORLAT E.I.R.L. · 66-41 · PERU — FDA import alert red lists: firms subject to detention without physical examination For ECORLAT E.I.R.L. · 66-41 · PERU, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is PERU; product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C; date published is 09/30/2009; address is Alfredo Salazar , # 228 , Lima/Mrafores, PE-LIM PERU, verified against its source on 2026-09-16. - **Firm:** ECORLAT E.I.R.L. _(verified: appears in the quote below)_ - **Import alert:** 66-41 - **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S. - **Country:** PERU _(verified: appears in the quote below)_ - **Address:** Alfredo Salazar , # 228 , Lima/Mrafores, PE-LIM PERU _(verified: appears in the quote below)_ - **Date published:** 09/30/2009 _(verified: appears in the quote below)_ - **Product code:** 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. _(verified: appears in the quote below)_ - **FDA notes:** 11/20/2007. Ercorlat. This product is sold as a dietary supplement containing papaya extract; garlic and other ingrediants. FDA analysis found furosemide in this product. Furosemide is the active ingrediant in the FDA approved drug Lasix and twenty nine other drug products. _(verified: appears in the quote below)_ ## What the source says > ECORLAT E.I.R.L. Date Published : 09/30/2009 Alfredo Salazar , # 228 , Lima/Mrafores, PE-LIM PERU 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 09/30/2009 Notes: 11/20/2007. Ercorlat. This product is sold as a dietary supplement containing papaya extract; garlic and other ingrediants. FDA analysis found furosemide in this product. Furosemide is the active ingrediant in the FDA approved drug Lasix and twenty nine other drug products. ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_190.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).